Alembic Ltd

Alembic is dealing in Active Pharmaceutical Ingredient (API) Business and Real Estate Business.

  • Market Cap: 1,443 Cr.
  • Current Price: 56.20
  • 52 weeks High / Low 63.60 / 31.58
  • Book Value: 51.86
  • Stock P/E: 5.68
  • Dividend Yield: 0.36 %
  • ROCE: 3.81 %
  • ROE: 18.48 %
  • Sales Growth (3Yrs): -2.62 %
  • Listed on BSE and NSE
  • Company Website
  • Face Value: 2.00
Pros:
Company is virtually debt free.
Stock is trading at 1.08 times its book value
Market value of investments Rs.3068.03 Cr. is more than the Market Cap Rs.1443.11 Cr.
Debtor days have improved from 55.69 to 39.83 days.
Promoter holding has increased by 1.87% over last quarter.
Cons:
Tax rate seems low
Earnings include an other income of Rs.37.99 Cr.
** Remarks:
Some businesses are provided tax benefits to encourage their development

Peer Comparison Sector: Pharmaceuticals // Industry: Pharmaceuticals - Indian - Bulk Drugs & Formln

Loading peers table ...

Quarterly Results Consolidated Figures in Rs. Crores / View Standalone

Dec 2015 Mar 2016 Dec 2016 Mar 2017 Dec 2017 Mar 2018 Jun 2018 Sep 2018 Dec 2018 Mar 2019 Jun 2019 Sep 2019
26 28 30 36 30 33 45 34 24 25 26 24
28 29 29 34 26 33 36 27 21 22 25 21
Operating Profit -2 -2 1 1 4 0 8 6 3 3 1 3
OPM % -9% -6% 2% 4% 14% 0% 19% 19% 13% 13% 5% 11%
Other Income -3 2 1 3 4 3 1 24 2 2 1 33
Interest 0 0 0 -0 0 0 0 0 0 0 0 0
Depreciation 1 2 1 1 1 1 1 1 1 1 1 1
Profit before tax -6 -2 1 3 8 3 9 30 4 5 2 34
Tax % 32% 24% 9% 15% 26% -81% 22% 2% 17% 19% 30% -2%
Net Profit 75 25 26 30 44 33 34 88 53 56 37 109
EPS in Rs 2.80 0.93 0.97 1.13 1.64 1.24 1.28 3.41 2.06 2.15 1.43 4.24
Notes Notes Notes Notes Notes Notes Notes Notes Notes Notes Notes Notes

Profit & Loss Consolidated Figures in Rs. Crores / View Standalone

Mar 2008 Mar 2009 Mar 2010 Mar 2015 Mar 2016 Mar 2017 Mar 2018 Mar 2019 TTM
990 1,099 1,121 144 134 147 125 124 99
848 1,016 1,018 134 131 143 114 106 89
Operating Profit 142 83 103 10 3 5 11 18 11
OPM % 14% 8% 9% 7% 3% 3% 9% 15% 11%
Other Income 39 7 16 21 28 27 37 29 38
Interest 35 42 32 1 0 0 0 0 0
Depreciation 33 38 43 6 6 5 4 3 3
Profit before tax 114 9 44 23 25 27 44 45 45
Tax % 1% -19% 10% -3% 2% -3% 5% 8%
Net Profit 112 11 40 107 235 145 163 213 254
EPS in Rs 0.78 0.36 1.44 3.96 8.75 5.44 6.10 8.30 9.88
Dividend Payout % 19% 51% 17% 4% 2% 4% 3% 2%
* Sales is net of excise duty and discounts
Compounded Sales Growth
10 Years:-19.62%
5 Years:%
3 Years:-2.62%
TTM:-29.68%
Compounded Profit Growth
10 Years:28.18%
5 Years:%
3 Years:-3.38%
TTM:27.95%
Stock Price CAGR
10 Years:12.10%
5 Years:9.49%
3 Years:24.91%
1 Year:62.52%
Return on Equity
10 Years:%
5 Years:%
3 Years:17.31%
Last Year:18.48%

Balance Sheet Consolidated Figures in Rs. Crores / View Standalone

Mar 2008 Mar 2009 Mar 2010 Mar 2015 Mar 2016 Mar 2017 Mar 2018 Mar 2019 Sep 2019
28 27 27 53 53 53 53 51 51
Reserves 314 304 311 474 750 858 1,032 1,157 1,280
Borrowings 423 475 408 0 9 0 0 0 0
181 209 251 96 68 87 80 63 49
Total Liabilities 946 1,015 997 624 880 998 1,166 1,271 1,381
367 405 393 169 146 171 179 209 217
CWIP 22 7 4 2 0 0 0 0 0
Investments 14 8 8 299 605 732 913 1,001 1,108
543 595 591 154 129 94 74 61 55
Total Assets 946 1,015 997 624 880 998 1,166 1,271 1,381

Cash Flows Consolidated Figures in Rs. Crores / View Standalone

Mar 2008 Mar 2009 Mar 2010 Mar 2015 Mar 2016 Mar 2017 Mar 2018 Mar 2019
54 123 149 22 10 52 24 22
-225 -56 -24 5 -5 -47 -22 68
39 -70 -118 -25 -5 -5 -3 -89
Net Cash Flow -133 -2 7 2 -0 -0 -1 1

Ratios Consolidated Figures in Rs. Crores / View Standalone

Mar 2008 Mar 2009 Mar 2010 Mar 2015 Mar 2016 Mar 2017 Mar 2018 Mar 2019
ROCE % 7% 10% 4% 4% 4% 4%
Debtor Days 85 71 63 122 76 54 74 40
Inventory Turnover 4.98 4.64 1.68 2.34 3.02 3.66

Recent Announcements

View all announcements

Annual Reports

Credit Ratings